ENDRA Life Sciences Inc. - Common Stock, par value $0.0001 per share (NDRA)
CUSIP: 29273B302
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 1,186,300
- Total 13F shares
- 817,275
- Share change
- +553,314
- Total reported value
- $79,348
- Price per share
- $0.10
- Number of holders
- 16
- Value change
- +$13,748
- Number of buys
- 14
- Number of sells
- 6
Quarterly Holders Quick Answers
What is CUSIP 29273B302?
CUSIP 29273B302 identifies NDRA - ENDRA Life Sciences Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 29273B302:
Top shareholders of NDRA - ENDRA Life Sciences Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Michael Milos Thornton |
3/4/5
|
Chief Technology Officer |
—
class O/S missing
|
34,139
|
$56,329 | — | 18 May 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
4.6%
|
54,242
|
$31,477 | — | 31 Mar 2024 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
4%
|
47,914
|
$27,790 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.4%
|
39,812
|
$23,091 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
3%
|
36,115
|
$20,947 | — | 31 Mar 2024 | |
| Virtu Financial LLC |
13F
|
Company |
2.9%
|
34,644
|
$20,000 | — | 31 Mar 2024 | |
| NewEdge Advisors, LLC |
13F
|
Company |
2.6%
|
30,937
|
$17,958 | — | 31 Mar 2024 | |
| XTX Topco Ltd |
13F
|
Company |
0.91%
|
10,758
|
$6,240 | — | 31 Mar 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.73%
|
8,656
|
$5,020 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.03%
|
332
|
$193 | — | 31 Mar 2024 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0.03%
|
329
|
$191 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
140
|
$81 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
66
|
$38 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
0%
|
16
|
$9 | — | 31 Mar 2024 | |
| Renaud Bertrand Maloberti |
3/4/5
|
Chief Commercial Officer |
—
class O/S missing
|
186,430
|
— | — | 28 Mar 2022 | |
| Francois Roger Michelon |
3/4/5
|
Chief Executive Officer, Director |
—
class O/S missing
|
69,531
|
— | — | 30 Jan 2023 | |
| Irina Pestrikova |
3/4/5
|
Senior Director, Finance |
—
class O/S missing
|
8,000
|
— | — | 30 Jan 2023 |
Institutional Holders of ENDRA Life Sciences Inc. - Common Stock, par value $0.0001 per share (NDRA) as of Q2 2024
As of 30 Jun 2024,
ENDRA Life Sciences Inc. - Common Stock, par value $0.0001 per share (NDRA) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
817,275 shares.
The largest 10 holders included
HRT FINANCIAL LP, JANE STREET GROUP, LLC, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, VANGUARD GROUP INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Tower Research Capital LLC (TRC), NewEdge Advisors, LLC, Kestra Advisory Services, LLC, and StoneX Group Inc..
This page lists
17
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
13
Q2 2024 holders
16
Holder diff
3
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.